Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label bevacizumab + weekly paclitaxel in first-line metastatic triple-negative breast cancer
2009-014279-37Phase 4Completed
- Sponsor
- Roche
- Start
- Oct 2009
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bevacizumab and paclitaxel in breast cancer, sponsored by Roche. Primary endpoint: Incidence of adverse events. Started Oct 2009; status: completed.
02
Drugs
bevacizumabpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2009-014279-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014279-37.